agilon health, inc. (AGL)
| Market Cap | 1.44B+223.4% |
| Revenue (ttm) | 5.92B |
| Net Income | -251.22M |
| EPS | -15.41 |
| Shares Out | 16.79M |
| PE Ratio | n/a |
| Forward PE | 36.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 355,685 |
| Open | 81.99 |
| Previous Close | 83.40 |
| Day's Range | 82.84 - 87.84 |
| 52-Week Range | 7.48 - 133.04 |
| Beta | 3.00 |
| Analysts | Buy |
| Price Target | 115.83(+35.16%) |
| Earnings Date | Nov 4, 2026 |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About AGL
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
$AGL stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in AGL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AGL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AGL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AGL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AGL from public contracts
Source: USAspending.gov
AGL Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from AGL’s recent data — informational, not investment advice